Literature DB >> 18165228

Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein.

Xiangjie Sun1, Sandrine Belouzard, Gary R Whittaker.   

Abstract

The glycoprotein of vesicular stomatitis virus (VSV G) mediates fusion of the viral envelope with the host cell, with the conformational changes that mediate VSV G fusion activation occurring in a reversible, low pH-dependent manner. Based on its novel structure, VSV G has been classified as class III viral fusion protein, having a predicted bipartite fusion domain comprising residues Trp-72, Tyr-73, Tyr-116, and Ala-117 that interacts with the host cell membrane to initiate the fusion reaction. Here, we carried out a systematic mutagenesis study of the predicted VSV G fusion loops, to investigate the functional role of the fusion domain. Using assays of low pH-induced cell-cell fusion and infection studies of mutant VSV G incorporated into viral particles, we show a fundamental role for the bipartite fusion domain. We show that Trp-72 is a critical residue for VSV G-mediated membrane fusion. Trp-72 could only tolerate mutation to a phenylalanine residue, which allowed only limited fusion. Tyr-73 and Tyr-116 could be mutated to other aromatic residues without major effect but could not tolerate any other substitution. Ala-117 was a less critical residue, with only charged residues unable to allow fusion activation. These data represent a functional analysis of predicted bipartite fusion loops of VSV G, a founder member of the class III family of viral fusion proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165228     DOI: 10.1074/jbc.M708955200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Characterization of Durham virus, a novel rhabdovirus that encodes both a C and SH protein.

Authors:  A B Allison; G Palacios; A Travassos da Rosa; V L Popov; L Lu; S Y Xiao; K DeToy; T Briese; W I Lipkin; M K Keel; D E Stallknecht; G R Bishop; R B Tesh
Journal:  Virus Res       Date:  2010-09-21       Impact factor: 3.303

2.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops.

Authors:  Brian P Hannah; Tina M Cairns; Florent C Bender; J Charles Whitbeck; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

4.  Generation of a caged lentiviral vector through an unnatural amino acid for photo-switchable transduction.

Authors:  Yan Wang; Shuai Li; Zhenyu Tian; Jiaqi Sun; Shuobin Liang; Bo Zhang; Lu Bai; Yuanjie Zhang; Xueying Zhou; Sulong Xiao; Qiang Zhang; Lihe Zhang; Chuanling Zhang; Demin Zhou
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

Review 5.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

6.  Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity.

Authors:  Stephen J Dollery; Catherine C Wright; David C Johnson; Anthony V Nicola
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

7.  Tracking fusion of human mesenchymal stem cells after transplantation to the heart.

Authors:  Brian T Freeman; Nicholas A Kouris; Brenda M Ogle
Journal:  Stem Cells Transl Med       Date:  2015-04-06       Impact factor: 6.940

8.  Baculovirus mediated transduction: analysis of vesicular stomatitis virus glycoprotein pseudotyping.

Authors:  Sujit M Kolangath; S H Basagoudanavar; M Hosamani; P Saravanan; R P Tamil Selvan
Journal:  Virusdisease       Date:  2014-10-11

9.  Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.

Authors:  Jean K Millet; Tiffany Tang; Lakshmi Nathan; Javier A Jaimes; Hung-Lun Hsu; Susan Daniel; Gary R Whittaker
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

Review 10.  Class III viral membrane fusion proteins.

Authors:  Marija Backovic; Theodore S Jardetzky
Journal:  Curr Opin Struct Biol       Date:  2009-04-06       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.